Protocol

A Post-Authorization Safety Study to Evaluate the Safety of Abrocitinib Exposure During Pregnancy in United States Healthcare Databases

April 4, 2024

Authors:

Harvard Pilgrim Health Care Institute, CVS Health, Carelon Research, HealthPartners Institute, Humana HealthCare Research, Pfizer, Inc.

Capability:

Pregnancy & Mother-Infant Linked Studies

Multi-Site Methods & Coordination

Expertise:

Regulatory Research & Support

RWE Research & Consulting